MPAM
Murphy Pohlad Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $830K | Sell |
1,580
-20
| -1% | -$10.5K | 0.35% | 72 |
|
|
2025
Q1 | $1.01M | Hold |
1,600
| – | – | 0.43% | 67 |
|
|
2024
Q4 | $1.14M | Hold |
1,600
| – | – | 0.49% | 64 |
|
|
2024
Q3 | $1.68M | Sell |
1,600
-100
| -6% | -$105K | 0.7% | 55 |
|
|
2024
Q2 | $1.79M | Sell |
1,700
-169
| -9% | -$178K | 0.77% | 51 |
|
|
2024
Q1 | $1.8M | Sell |
1,869
-5
| -0.3% | -$4.81K | 0.7% | 53 |
|
|
2023
Q4 | $1.65M | Sell |
1,874
-1,115
| -37% | -$979K | 0.68% | 53 |
|
|
2023
Q3 | $2.46M | Sell |
2,989
-130
| -4% | -$107K | 1.08% | 37 |
|
|
2023
Q2 | $2.24M | Sell |
3,119
-172
| -5% | -$124K | 0.97% | 43 |
|
|
2023
Q1 | $2.7M | Sell |
3,291
-124
| -4% | -$102K | 1.12% | 40 |
|
|
2022
Q4 | $2.46M | Sell |
3,415
-118
| -3% | -$85.1K | 1.01% | 43 |
|
|
2022
Q3 | $2.43M | Sell |
3,533
-100
| -3% | -$68.9K | 1.13% | 39 |
|
|
2022
Q2 | $2.15M | Sell |
3,633
-50
| -1% | -$29.5K | 0.94% | 45 |
|
|
2022
Q1 | $2.57M | Hold |
3,683
| – | – | 1.04% | 40 |
|
|
2021
Q4 | $2.33M | Sell |
3,683
-90
| -2% | -$56.8K | 0.91% | 43 |
|
|
2021
Q3 | $2.28M | Buy |
3,773
+966
| +34% | +$585K | 0.93% | 44 |
|
|
2021
Q2 | $1.57M | Buy |
2,807
+75
| +3% | +$41.9K | 0.63% | 55 |
|
|
2021
Q1 | $1.29M | Hold |
2,732
| – | – | 0.56% | 53 |
|
|
2020
Q4 | $1.32M | Hold |
2,732
| – | – | 0.65% | 51 |
|
|
2020
Q3 | $1.53M | Buy |
2,732
+105
| +4% | +$58.8K | 0.81% | 49 |
|
|
2020
Q2 | $1.64M | Buy |
2,627
+255
| +11% | +$159K | 0.92% | 47 |
|
|
2020
Q1 | $1.16M | Buy |
+2,372
| New | +$1.16M | 0.79% | 47 |
|